Literature DB >> 686702

Dihydrofolate reductases in some folate-requiring bacteria with low trimethoprim susceptibility.

R L Then, H Riggenbach.   

Abstract

Dihydrofolate reductases from the folate-requiring strains Streptococcus faecalis ATCC 8043, Lactobacillus casei ATCC 7496, and Pediococcus cerevisiae ATCC 8081, as well as from Lactobacillus arabinosus, which is not dependent on exogenous folate, were isolated, and their properties were compared to reductases of Escherichia coli B, Staphylococcus aureus, and rat liver reductase. An inhibition profile with six different inhibitors revealed significant differences among all enzymes. All lactobacilli reductases are less sensitive to trimethoprim than the enzymes of E. coli and S. aureus, the reductase of P. cerevisiae requiring a concentration at least 1,000 times higher for 50% inhibition. Inhibition of growth of S. faecalis by pyrimethamine and 2,4-diamino-6,7-diisopropyl-pteridine was seen to be much stronger than was predicted from the enzymatic data.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 686702      PMCID: PMC352413          DOI: 10.1128/AAC.14.1.112

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups.

Authors:  K H Pattishall; J Acar; J J Burchall; F W Goldstein; R J Harvey
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

2.  The relationship of cellular permeability to the degree of inhibition by amethopterin and pyrimethamine in several species of bacteria.

Authors:  R C WOOD; R FERONE; G H HITCHINGS
Journal:  Biochem Pharmacol       Date:  1961-05       Impact factor: 5.858

3.  A study of the uptake and degradation of folic acid, citrovorum factor, aminopterin, and pyrimethamine by bacteria.

Authors:  R C WOOD; G H HITCHINGS
Journal:  J Biol Chem       Date:  1959-09       Impact factor: 5.157

4.  The pharmacological basis for the prolonged antimalarial activity of pyrimethamine.

Authors:  C C SMITH; J IHRIG
Journal:  Am J Trop Med Hyg       Date:  1957-01       Impact factor: 2.345

5.  Dihydrofolate reductase in Pediococcus cerevisiae strains susceptible and resistant to amethopterin.

Authors:  F Mandelbaum-Shavit; N Grossowicz
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

6.  Dihydrofolate reductase from Lactobacillus casei: N-terminal sequence and comparison with the substrate binding region of other reductases.

Authors:  K E Batley; H R Morris
Journal:  Biochem Biophys Res Commun       Date:  1977-04-25       Impact factor: 3.575

7.  Amino acid sequence of dihydrofolate reductase from an amethopterin-resistant strain of Lactobacillus casei.

Authors:  K G Bitar; D T Blankenship; K A Walsh; R B Dunlap; A V Reddy; J H Freisheim
Journal:  FEBS Lett       Date:  1977-08-01       Impact factor: 4.124

8.  The amino-acid sequence of the dihydrofolate reductase of a trimethoprim-resistant strain of Escherichia coli.

Authors:  D Stone; A W Phillips; J J Burchall
Journal:  Eur J Biochem       Date:  1977-02

9.  Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli.

Authors:  C S Genther; C S Smith
Journal:  J Med Chem       Date:  1977-02       Impact factor: 7.446

10.  Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.

Authors:  J B Hynes; D E Eason; C M Garrett; P L Colvin
Journal:  J Med Chem       Date:  1977-04       Impact factor: 7.446

View more
  3 in total

1.  Low trimethoprim susceptibility of anaerobic bacteria due to insensitive dihydrofolate reductases.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

Review 2.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

3.  High-level resistance to trimethoprim in clinical isolates of Campylobacter jejuni by acquisition of foreign genes (dfr1 and dfr9) expressing drug-insensitive dihydrofolate reductases.

Authors:  A Gibreel; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.